New cancer clinical trial: Real World Study of First Line Crizotinib for ALK Rearranged Non-squamous Non-small Cell Lung Cancer

Published on: August 27, 2018 at 12:00PM
Condition:   Non-small Cell Lung Cancer
Intervention:   Drug: Crizotinib
Sponsor:   Hunan Province Tumor Hospital
Recruiting
https://ift.tt/2MXWGpF